For the first biochip readouts, we concentrate on the quantification of cancer-relevant proteins on so-called reverse phase arrays. This is intended to increase the data gain from high throughput screens and to add readout options. The figure shows a first test chip for the detection and quantification of the p53 protein, which was spotted at a density allowing for positioning 12,000 samples on a chip with the size of a microscopic slide.